Unknown

Dataset Information

0

PPARG Polymorphisms Are Associated with Unexplained Mild Vision Loss in Patients with Type 2 Diabetes Mellitus.


ABSTRACT: Objectives:To investigate whether the presence of peroxisome proliferator-activated receptor gamma (PPARG) gene polymorphisms is associated with unexplained mild visual impairment (UMVI) in patients with type 2 diabetes mellitus (T2DM). Methods:A total of 135 T2DM residents with UMVI and 133 with normal vision (NV; best-corrected visual acuity???20/25 in both eyes) were enrolled. UMVI was defined as best-corrected visual acuity (BCVA)? 0.05). The frequency of genotype GC at SNP rs10865710 was significantly higher in the UMVI group than in the NV group (p < 0.001; GG?+?GC versus CC) (OR?=?8.94, 95% CI: 4.90-16.31), whereas genotype CC decreased the risk (OR?=?0.07, 95% CI: 0.03-0.14). Genotype TT at SNP rs3856806 was strongly associated with UMVI (p < 0.0001, TT?+?TC versus CC) (OR?=?4.74, 95% CI: 2.68-8.54), whereas genotype CC appeared to be protective for UMVI (OR?=?0.55, 95% CI: 0.37-0.82). Conclusions:Susceptibilities of PPARG variants may lead to differences in PPARG transcription, result in early function loss of retinal photoreceptor cells, and eventually cause UMVI.

SUBMITTER: Li T 

PROVIDER: S-EPMC6930731 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

PPARG Polymorphisms Are Associated with Unexplained Mild Vision Loss in Patients with Type 2 Diabetes Mellitus.

Li Tao T   Xu Xian X   Xu Yi Y   Jin Peiyao P   Chen Jianhua J   Shi Yongyong Y   Zou Haidong H  

Journal of ophthalmology 20191212


<h4>Objectives</h4>To investigate whether the presence of peroxisome proliferator-activated receptor gamma (PPARG) gene polymorphisms is associated with unexplained mild visual impairment (UMVI) in patients with type 2 diabetes mellitus (T2DM).<h4>Methods</h4>A total of 135 T2DM residents with UMVI and 133 with normal vision (NV; best-corrected visual acuity ≥ 20/25 in both eyes) were enrolled. UMVI was defined as best-corrected visual acuity (BCVA) < 20/25 and ≥ 20/63 in both eyes, with no visu  ...[more]

Similar Datasets

| S-EPMC2843807 | biostudies-literature
| S-EPMC6525561 | biostudies-literature
| S-EPMC6142339 | biostudies-literature
| S-EPMC8630345 | biostudies-literature
| S-EPMC3850115 | biostudies-literature
| S-EPMC5244830 | biostudies-literature
| S-EPMC4127584 | biostudies-literature
| S-EPMC10095581 | biostudies-literature
| S-EPMC10442246 | biostudies-literature
| S-EPMC4297945 | biostudies-literature